[artículo] 
inEuropean Neuropsychopharmacology > Año 2015 - Vol. 25 - No.3 (Marzo) . - pp. 377-385

Título :	A pharmacokinetic/pharmacodynamic investigation : Assessment of edivoxetine and atomoxetine on systemic and central 3,4-dihydroxyphenylglycol, a biochemical marker for norepinephrine transporter inhibition
Tipo de documento:	texto impreso
Autores:	William B. Kielbasa, Autor ; Alan Pan, Autor ; Alvaro Pereira, Autor
Fecha de publicación:	2021
Artículo en la página:	pp. 377-385
Idioma :	Inglés (eng) Idioma original : Inglés (eng)
Palabras clave:	Edivoxetina, DHPG, Farmacocinética, Farmacodinamia, Atomoxetina
Resumen:	Inhibition of norepinephrine (NE) reuptake into noradrenergic nerves is a common therapeutic target in the central nervous system (CNS). In noradrenergic nerves, NE is oxidized by monoamine oxidase to 3,4-dihydroxyphenylglycol (DHPG).
Link:	./index.php?lvl=notice_display&id=26818

[artículo] A pharmacokinetic/pharmacodynamic investigation : Assessment of edivoxetine and atomoxetine on systemic and central 3,4-dihydroxyphenylglycol, a biochemical marker for norepinephrine transporter inhibition [texto impreso] / William B. Kielbasa, Autor ; Alan Pan, Autor ; Alvaro Pereira, Autor . - 2021 . - pp. 377-385.
Idioma : Inglés (eng) Idioma original : Inglés (eng)
in European Neuropsychopharmacology > Año 2015 - Vol. 25 - No.3 (Marzo) . - pp. 377-385

Palabras clave:	Edivoxetina, DHPG, Farmacocinética, Farmacodinamia, Atomoxetina
Resumen:	Inhibition of norepinephrine (NE) reuptake into noradrenergic nerves is a common therapeutic target in the central nervous system (CNS). In noradrenergic nerves, NE is oxidized by monoamine oxidase to 3,4-dihydroxyphenylglycol (DHPG).
Link:	./index.php?lvl=notice_display&id=26818